Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-20-043792
Filing Date
2020-12-21
Accepted
2020-12-21 16:05:38
Documents
3
Period of Report
2021-02-09
Effectiveness Date
2020-12-21

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea131488-def14a_citiuspharma.htm DEF 14A 288683
2 GRAPHIC proxy_001.jpg GRAPHIC 335729
3 GRAPHIC proxy_002.jpg GRAPHIC 151097
  Complete submission text file 0001213900-20-043792.txt   927966
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 001-38174 | Film No.: 201404409
SIC: 2834 Pharmaceutical Preparations